The Science of Aging: An IOA Newsletter | Fall 2023 Edition
The Science of Aging: An IOA Newsletter, Fall 2023 Edition | DIGITAL VERSION
- TRIM11: A promising target for developing Alzheimer's Disease treatment
-
Detailed 3D Mapping of AD Pathology Using Ex Vivo Imaging of the MTL
-
FDA Fully Approves Lecanemab for Treatment of Alzheimerâs Disease
TRIM11: A promising target for developing Alzheimerâs Disease treatment
Penn Medicine researchers…
View Full Post